[Acetaldehyde-induced leukocyte migration inhibition in alcoholic liver diseases].
Acetaldehyde in non-toxic doses (15.6 micrograms per start) causes in the inhibition test of the migration of leucocytes an inhibition of the migration in 6/13 of the patients with alcoholic hepatitis, a stimulation of the migration in 6/11 of alcohol cirrhoses. Healthy (n = 16) persons, patients with alcoholic fatty degeneration of the liver (n = 3) as well as non-alcoholic liver diseases (chronic persisting hepatitis, n = 11; chronic active hepatitis, n = 8, cirrhosis, n = 7) did not show this cellular immune reagibility. The inhibition of the migration and the stimulation of the migration, respectively, might develop by hapten autoantigen complexes (altered cytoskeleton?) with release of the factors of inhibition of migration and stimulation of migration, in which case the role of a hapten belongs to acetaldehyde. The results of the tests did not correlate with functional and histological findings of the liver, with the actual consumption of alcohol and also not with haptoglobin phaenotypes. When it is postulated that by acetaldehyde also the release of further lymphokines is mediated, origin and progression of alcoholic hepatitis and alcoholic cirrhosis might be explained immunopathogenetically.
D000079:Acetaldehyde / Q000009:adverse effects*; D002464:Cell Migration Inhibition; D006519:Hepatitis, Alcoholic / Q000276:immunology; D006801:Humans; D007962:Leukocytes / Q000187:drug effects* / Q000276:immunology; D008104:Liver Cirrhosis, Alcoholic / Q000276:immunology; D008108:Liver Diseases, Alcoholic / Q000097:blood / Q000276:immunology*; D008214:Lymphocytes / Q000378:metabolism; D008222:Lymphokines / Q000378:metabolism
D008222:Lymphokines; D000079:Acetaldehyde
Azetaldehydinduzierte Leukozytenmigrationshemmung bei alkoholischen Lebererkrankungen.